Résultats de la recherche - 6 results
Interim analysis of COVID-19 vaccine effectiveness against hospitalisation and death using electronic health records in six European countries
mostly ≤50% between April 2022 and March 2023 in all age groups (with a few point estimates >50%). It waned 12 weeks after administration and dropped even lower after 24 weeks. In the most recent ...
Factors underlying COVID-19 booster vaccine uptake among adults in Belgium
variables. Among adults, there was generally a higher uptake to receive the first booster among older age groups compared to younger ones. Females, individuals residing in Flanders and those with no previous ...
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.
Anthony; Nicolay, Nathalie; Monge, Susana; VEBIS-Lot4 working group Source: Influenza Other Respir Viruses, Volume 17, Issue 11 (2023) Keywords: Aged COVID-19 COVID-19 Vaccines Electronics Hospitalization ...
Regulatory issues regarding manufacture and control of vaccine adjuvants. The EU situation.
at batch release Belgian Change Clinical clinical trial Clinical trials Combination Components Control developing Development distribution EU European future Group Guidelines health Hepatitis Hepatitis ...
Differences in Antigenic Structure of Inactivated Polio Vaccines Made From Sabin Live-Attenuated and Wild-Type Poliovirus Strains: Impact on Vaccine Potency Assays.
Publication Type: Peer reviewed scientific article Authors: Laura Crawt; Eleanor Atkinson; Alison Tedcastle; Elaine Pegg; sIPV Study Group; Philip Minor; Gillian Cooper; Peter Rigsby; Javier Martin; ...
Immunology group presentation
Publication Type: Scientific poster, presentation or proceeding Authors: S. Clouet; J. Auquier; F. Masquelier; C. Domicent Source: (0) Health Topics: Vaccin Vaccin Vaccin Service: Qualité des vaccins et produits sanguins Kwaliteit van vaccins en bloedpr ...